Report date: Apr 23, 2024
Conflict count: 350216
Publisher: AME Publishing Company
Title count: 21
Conflict count: 68


==========================================================

Created: 2022-04-28 23:14:35.0
ConfID: 6478790
CauseID: 1527855215
OtherID: 1474538202
JT: Translational Breast Cancer Research
MD: Perachino, 1 ,null,11,2020,Pyrotinib: a new promising targeted agent for human epidermal growth factor receptor 2-positive breast cancer
DOI: 10.21037/tbcr.2020-20-34(Journal) (6478790-N )
DOI: 10.21037/tbcr-20-34(Journal)